Botswana: MRI incorrectly assumes charges cleared, says Competition Authority
A miscommunication between MRI Botswana and the Competition Authority may have lead to a premature celebration by the emergency medical care company. According to reports, MRI misinterpreted the Competition Authority’s decision to no longer investigate MRI for alleged abuse of dominance practices as a ruling that the Competition Authority did not find MRI guilty of antitrust violations; the Competition Authority, however, says it did not make a ruling and that the issue may still be referred to the Competition Commission. The Competition Authority said in a statement that the decision to end the investigation was made after the Authority did, in fact, find exclusive dealing within MRI, but that it followed an open tender process.
Featured News
CFTC Moves To East Reporting Requirements for Prediction Markets
May 16, 2026 by
CPI
California’s Settlement With GM Signals Closer Scrutiny of Data Sales
May 16, 2026 by
CPI
Jury in Boston Set to Decide Takeda’s Fate in Amitiza Antitrust Trial
May 14, 2026 by
CPI
OnlyFans Faces New Antitrust Lawsuit
May 14, 2026 by
CPI
Americans’ Opposition to Hosting AI Data Centers Hardens, Survey Finds
May 14, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Unilateral Effects
Apr 28, 2026 by
CPI
A Net Present Value Approach to Merger Analysis
Apr 28, 2026 by
Joseph J Simons & Malcolm Coate
Generative AI and Competitive Disruption: Increasingly Relevant for Merger Analysis?
Apr 28, 2026 by
Andrea Coscelli, Emily Chissell, Nitika Bagaria & Tega Akati-Udi
Non-Price Unilateral Effects In Media Mergers
Apr 28, 2026 by
Lapo Filistrucchi & Teresa Oriani
Ecosystem Mergers and Unilateral Effects? A Framework for Assessing the Ecosystem Theory of Harm
Apr 28, 2026 by
Ethel Fonseca, George Tucker & Helder Vasconcelos